Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
Apr 28, 2026
Sale
Shares
53
Price
$156.61
Total Value
$8.30K
Shares Held After
7,593
% of Holdings
0.7%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
Apr 28, 2026
Sale
Shares
8
Price
$155.36
Total Value
$1.24K
Shares Held After
7,646
% of Holdings
0.1%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
Apr 28, 2026
Sale
Shares
12
Price
$154.65
Total Value
$1.86K
Shares Held After
7,654
% of Holdings
0.2%
Apr 28, 2026
Purchase
Shares
10,000
Price
$4.52
Total Value
$45.18K
Shares Held After
3,062,000
% of Holdings
0.3%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Apr 27, 2026
Sale
Shares
931
Price
$89.70
Total Value
$83.51K
Shares Held After
2,198,750
% of Holdings
0.0%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Apr 27, 2026
Sale
Shares
2,819
Price
$88.98
Total Value
$250.83K
Shares Held After
2,199,681
% of Holdings
0.1%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Apr 27, 2026
Sale
Shares
1,185
Price
$204.39
Total Value
$242.20K
Shares Held After
145,700
% of Holdings
0.8%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Apr 27, 2026
Sale
Shares
997
Price
$203.75
Total Value
$203.14K
Shares Held After
146,885
% of Holdings
0.7%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Apr 27, 2026
Sale
Shares
1,222
Price
$204.39
Total Value
$249.76K
Shares Held After
61,361
% of Holdings
2.0%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Apr 27, 2026
Sale
Shares
188
Price
$204.39
Total Value
$38.43K
Shares Held After
258,782
% of Holdings
0.1%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Apr 27, 2026
Sale
Shares
771
Price
$203.75
Total Value
$157.09K
Shares Held After
62,583
% of Holdings
1.2%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Apr 27, 2026
Sale
Shares
285
Price
$203.75
Total Value
$58.07K
Shares Held After
258,970
% of Holdings
0.1%
Apr 27, 2026
Sale
Shares
3,566
Price
$204.39
Total Value
$728.85K
Shares Held After
150,769
% of Holdings
2.3%

Natera, Inc. (NTRA)

Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Apr 27, 2026
Sale
Shares
917
Price
$204.39
Total Value
$187.43K
Shares Held After
187,511
% of Holdings
0.5%

Natera, Inc. (NTRA)

Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Apr 27, 2026
Sale
Shares
771
Price
$203.75
Total Value
$157.09K
Shares Held After
188,428
% of Holdings
0.4%
Apr 27, 2026
Sale
Shares
2,272
Price
$203.75
Total Value
$462.92K
Shares Held After
154,335
% of Holdings
1.5%

Natera, Inc. (NTRA)

RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Apr 27, 2026
Sale
Shares
988
Price
$204.39
Total Value
$201.94K
Shares Held After
223,024
% of Holdings
0.4%

Natera, Inc. (NTRA)

RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Apr 27, 2026
Sale
Shares
873
Price
$203.75
Total Value
$177.87K
Shares Held After
224,012
% of Holdings
0.4%
Apr 27, 2026
Sale
Shares
53,940
Price
$0.85
Total Value
$45.85K
Shares Held After
2,105,920
% of Holdings
2.5%
Apr 27, 2026
Sale
Shares
19,037
Price
$14.23
Total Value
$270.90K
Shares Held After
377,802
% of Holdings
4.8%
Apr 27, 2026
Sale
Shares
32
Price
$4.13
Total Value
$132.16
Shares Held After
9,556,063
% of Holdings
0.0%

Revolution Medicines, Inc. (RVMD)

Mancini Anthony — Chief Global Commercialization Officer
Apr 27, 2026
Sale
Shares
400
Price
$134.34
Total Value
$53.73K
Shares Held After
54,400
% of Holdings
0.7%

Revolution Medicines, Inc. (RVMD)

Mancini Anthony — Chief Global Commercialization Officer
Apr 27, 2026
Sale
Shares
1,049
Price
$132.88
Total Value
$139.39K
Shares Held After
54,800
% of Holdings
1.9%

Revolution Medicines, Inc. (RVMD)

Mancini Anthony — Chief Global Commercialization Officer
Apr 27, 2026
Sale
Shares
1,671
Price
$131.66
Total Value
$220.01K
Shares Held After
55,849
% of Holdings
2.9%
Apr 27, 2026
Sale
Shares
599,800
Price
$0.01
Total Value
$7.50K
Shares Held After
24,493,200
% of Holdings
2.4%

NewcelX Ltd. (NCEL)

Samuel Olivier — Director
Apr 27, 2026
Purchase
Shares
81,818
Price
$2.75
Total Value
$225.00K
Shares Held After
81,818
% of Holdings
100.0%
Apr 27, 2026
Sale
Shares
500
Price
$61.83
Total Value
$30.91K
Shares Held After
25,222
% of Holdings
1.9%
Apr 27, 2026
Sale
Shares
400
Price
$462.66
Total Value
$185.06K
Shares Held After
25,051
% of Holdings
1.6%

NewcelX Ltd. (NCEL)

Revel Michel — Director
Apr 27, 2026
Purchase
Shares
54,545
Price
$2.75
Total Value
$150.00K
Shares Held After
957,530
% of Holdings
5.7%

Liquidia Corp (LQDA)

Adair Jason — Chief Business Officer
Apr 27, 2026
Sale
Shares
688
Price
$41.65
Total Value
$28.66K
Shares Held After
214,738
% of Holdings
0.3%
Apr 27, 2026
Sale
Shares
14,363
Price
$30.46
Total Value
$437.50K
Shares Held After
199,154
% of Holdings
6.7%
Apr 27, 2026
Sale
Shares
29,623
Price
$29.60
Total Value
$876.84K
Shares Held After
213,517
% of Holdings
12.2%
Apr 27, 2026
Sale
Shares
7,914
Price
$28.94
Total Value
$229.03K
Shares Held After
243,140
% of Holdings
3.2%

Liquidia Corp (LQDA)

Boyle Dana — Chief Accounting Officer
Apr 27, 2026
Sale
Shares
1,576
Price
$37.78
Total Value
$59.54K
Shares Held After
175,342
% of Holdings
0.9%

MapLight Therapeutics, Inc. (MPLT)

Kreitzer Anatol — Chief Discovery Officer
Apr 27, 2026
Sale
Shares
7,821
Price
$30.50
Total Value
$238.54K
Shares Held After
211,190
% of Holdings
3.6%

MapLight Therapeutics, Inc. (MPLT)

Kreitzer Anatol — Chief Discovery Officer
Apr 27, 2026
Sale
Shares
29,255
Price
$29.63
Total Value
$866.83K
Shares Held After
219,011
% of Holdings
11.8%

MapLight Therapeutics, Inc. (MPLT)

Kreitzer Anatol — Chief Discovery Officer
Apr 27, 2026
Sale
Shares
8,346
Price
$28.96
Total Value
$241.70K
Shares Held After
248,266
% of Holdings
3.3%

WEST PHARMACEUTICAL SERVICES INC (WST)

Favorite Annette F — Sr. VP & Chief HR Officer
Apr 27, 2026
Sale
Shares
2,817
Price
$305.20
Total Value
$859.75K
Shares Held After
16,828
% of Holdings
14.3%

WEST PHARMACEUTICAL SERVICES INC (WST)

Winters Chad — VP, Chief Accounting Officer
Apr 27, 2026
Sale
Shares
896
Price
$300.67
Total Value
$269.40K
Shares Held After
1,523
% of Holdings
37.0%
Apr 27, 2026
Purchase
Shares
10,000
Price
$92.65
Total Value
$926.54K
Shares Held After
6,751,103
% of Holdings
0.1%

Bicara Therapeutics Inc. (BCAX)

Raben David — Chief Medical Officer
Apr 27, 2026
Sale
Shares
5,500
Price
$22.88
Total Value
$125.83K
Shares Held After
55,286
% of Holdings
9.0%
Apr 27, 2026
Sale
Shares
120
Price
$572.22
Total Value
$68.67K
Shares Held After
40,513
% of Holdings
0.3%
Apr 27, 2026
Sale
Shares
1,417
Price
$571.49
Total Value
$809.80K
Shares Held After
40,633
% of Holdings
3.4%
Apr 27, 2026
Sale
Shares
1,653
Price
$570.57
Total Value
$943.16K
Shares Held After
42,050
% of Holdings
3.8%
Apr 27, 2026
Sale
Shares
1,891
Price
$569.75
Total Value
$1.08M
Shares Held After
43,703
% of Holdings
4.1%
Apr 27, 2026
Sale
Shares
583
Price
$568.58
Total Value
$331.48K
Shares Held After
45,594
% of Holdings
1.3%
Apr 27, 2026
Sale
Shares
1,023
Price
$567.61
Total Value
$580.67K
Shares Held After
46,177
% of Holdings
2.2%
Apr 27, 2026
Sale
Shares
1,311
Price
$566.56
Total Value
$742.76K
Shares Held After
47,200
% of Holdings
2.7%
Apr 27, 2026
Sale
Shares
1,502
Price
$565.75
Total Value
$849.76K
Shares Held After
48,511
% of Holdings
3.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 27, 2026
Sale
Shares
649
Price
$571.92
Total Value
$371.18K
Shares Held After
18,876
% of Holdings
3.3%
Version: v26.5.2